Tempus AI TEM is transitioning from a heavy-investment growth stage toward improved operating leverage and a more scalable ...

Relation's draw is its 'lab-in-a-loop' process of AI-driven target and drug discovery, in which algorithms are used to find ...

Piper Sandler 37th Annual Healthcare Conference December 3, 2025 10:30 AM ESTCompany ParticipantsJames Rogers - Chief ...

Until improvements under development can be broadly implemented, routine confirmatory testing in active surveillance for ...

Two Ark Invest ETFs added Tempus AI stock to their holdings last Friday. A BTIG analyst sees significant upside to Tempus AI stock. Growth investors shouldn't dismiss Tempus AI stock solely based on ...

Two Ark Invest ETFs added Tempus AI stock to their holdings last Friday. A BTIG analyst sees significant upside to Tempus AI stock. According to data provided by S&P Global Market Intelligence, Tempus ...

A well-known analyst believes this AI healthcare stock has room to soar. According to data provided by S&P Global Market Intelligence, Tempus AI stock rose 10.9% from the end of last Friday's market ...

Sifting through countless of stocks in the Life Sciences Tools & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Alphabet is an unstoppable stock billionaires are loading ...

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

DEVELOPMENTS FROM FREDERICK. THE INVESTMENT PROVIDES AN ECONOMIC SHOT IN THE ARM, CREATES JOBS AND BOOSTS THE STATE’S EFFORT TO EXPAND MARYLAND’S LIFE SCIENCES SECTOR. TODAY IS ABOUT SHOWING THAT WE ...

Investment supports 2,600 jobs, including 300 highly skilled positions AstraZeneca's expansion aligns with Trump's domestic manufacturing push Announcement is part of drugmaker's $50 billion ...